Looking for new antibiotic families.
Researchers used explainable deep learning to identify a structural class of antibiotic candidates.
Original sources ↓ · Revision history ↓
Experimental · source published 2023-12-20
The human problem
Drug resistance creates demand for new classes of antibiotics.
The prior constraint
Laboratory screening cannot easily cover huge chemical libraries.
AI’s actual role
Models predicted activity and highlighted chemical substructures.
The documented result
Candidate compounds showed antibacterial activity, including tests in mouse models.
Why it may matter
The results offer starting points for drug development.
Limitations
Preclinical findings do not demonstrate human safety or effectiveness.
Unresolved questions
Optimize candidates and establish safety.
Source history & evidence assessment
- Maturity
- Experimental
- Claim confidence
- unassessed
- Event date
- Not recorded
- Source published
- 2023-12-20
- Captured
- Not recorded
- Last source review
- 2026-09-05
- Editorial method
- Original source check
- Place / relevance
- Cambridge, United States · institution-location
Legacy source check; no named human reviewer is recorded in this projection.
Maturity describes the tested or operational setting. Confidence describes support for the particular claim; one does not determine the other.
Original sources
Discovery of a structural class of antibiotics with explainable deep learning ↗ · paper
Institutions: MIT & collaborators
Explore the underlying question
Related developments
Editorial connections between distinct settings and results; these links do not imply replication.
Revision & correction history
No corrections recorded.
